HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Erythrocyte uroporphyrinogen I synthase in rats treated with the hepatic carcinogen diethylnitrosamine.

Abstract
Uroporphyrinogen I Synthase (URO-S) activity was measured in erythrocytes of female and male rats which had received diethylnitrosamine (DENA) as an inducer of hepatic tumors. Twenty-two weeks after the last dose of the carcinogen, the rats showed statistically significant increases in the URO-S activity. Differences in the body weight, erythrocyte porphyrin content or the hematocrit between treated and control rats were not found. Fifty percent of female rats and thirty percent of male rats treated with DENA were found to have hepatic tumors but there was no correlation between blood URO-S activity and tumoral development in spite of the increase in URO-S activity observed in DENA treated rats. This was observed both in male and female rats.
AuthorsR W de Calmanovici, A C Cochón, C A Aldonatti, J R Cabral, L C San Martín de Viale
JournalActa physiologica, pharmacologica et therapeutica latinoamericana : organo de la Asociacion Latinoamericana de Ciencias Fisiologicas y [de] la Asociacion Latinoamericana de Farmacologia (Acta Physiol Pharmacol Ther Latinoam) Vol. 45 Issue 1 Pg. 49-52 ( 1995) ISSN: 0327-6309 [Print] Argentina
PMID8580519 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Diethylnitrosamine
  • Hydroxymethylbilane Synthase
Topics
  • Animals
  • Carcinoma, Hepatocellular (enzymology)
  • Diethylnitrosamine (therapeutic use)
  • Erythrocytes (metabolism)
  • Female
  • Hydroxymethylbilane Synthase (blood, metabolism)
  • Liver Neoplasms (enzymology)
  • Male
  • Rats

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: